Interested in Connecting? Please contact: Thomas Mehrling CEO email@example.com
Message the company or request a 1:1 meeting here.
Laevoroc is a group of oncology drug development companies based in Zug, Switzerland. The company was founded in 2019 by two oncology drug development visionaries (with proven tracks records at Takeda, Mundipharma and Roche, and) with the purpose of bringing game-changing medicines to patients living with cancer. Founded on deep expertise, the company’s pipeline spans breakthrough innovation and re-imagining of approved therapies. This diversified approach to innovation in cancer therapeutics combines the pragmatic with the visionary, with a rock-solid determination to shape a better life for cancer patients.